http://www.cbsnews.com/news/fda-lift...-drug-tekmira/
'The U.S. Food and Drug Administration has eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus.
Canadian drugmaker Tekmira Pharmaceuticals Corp. said the FDA modified a hold recently placed on the company's drug after safety issues emerged in human testing.
The company has a $140 million contract with the U.S. government to develop its drug, TKM-Ebola, which targets the genetic material of Ebola. But last month the FDA halted a small study of the injection in adults to request additional safety information.'